Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis

Inclusion Criteria: * Patients between 18 and 80 years old. * Clinical criteria and/or analytical, ultrasound and/or liver biopsy consistent with the diagnosis of liver cirrhosis. * Endoscopic Diagnosis of esophageal variceal bleeding within 5 days prior to study inclusion. * Written informed consent to participate in the study. * Child C status, CTP \>10 Exclusion Criteria: * Pregnancy or lactation * Serum Creatinine \> 2 mg/dl * Bleeding due to gastric varices. * Active infection or recent infection \< 2 weeks * Presence of hepatocellular carcinoma or portal vein thrombosis * Active alcoholism * Pregnancy * HIV infection * Severe heart, respiratory or contraindications for beta blockers(severe chronic obstructive pulmonary disease, severe asthma, severe insulin-dependent diabetes mellitus, Brady arrhythmia) * Not giving consent